2026-525234-39-00招募中1 期
A Phase 1 Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 175
- 试验地点
- 17
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
CTIS Point of Contact
Scientific
Janssen Cilag International
研究点 (17)
Loading locations...
相似试验
招募中
1 期
A Phase 1 Study of JNJ-87562761 in Relapsed/Refractory Multiple MyelomaRelapsed/Refractory Multiple Myeloma2024-513439-25-00Janssen Cilag International15
招募中
3 期
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's DiseaseCrohn DiseaseNCT07577843Janssen Research & Development, LLC460
招募中
3 期
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative ColitisColitis, UlcerativeNCT07577856Janssen Research & Development, LLC644
尚未招募
不适用
A Study of JNJ-89402638 for Metastatic Colorectal and Gastric CancersColorectal Neoplasms, Gastrointestinal NeoplasmsjRCT2041260049260
招募中
2 期
A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic ArthritisArthritis, PsoriaticNCT07321873Janssen Research & Development, LLC240